Newsletter | July 2, 2020

07.02.20 -- Solving Oral Dose Development Challenges

The Next-Generation ODT

Orally dissolving tablets (ODT) are designed to dissolve rapidly on contact with saliva, therefore eliminating the need to chew the tablet, swallow the intact tablet, or take the tablet with liquids. View the webinar to get an overview of Zydis ODT technology. The webinar also presents the highlights of Zydis Ultra that can provide a better solution in terms of improved taste masking, functional coating, and a wide range of applications.

Zydis ODT Provides Better Treatments

Discover how Zydis ODT oral drug delivery offerings can help get your molecule to market faster. In this case study, learn the many benefits of these drug delivery offerings, including an improved therapeutic profile, patient preference and adherence to prescriptions, and improved market performance.

Patient-Centric Drug Design: A Clinical And Academic Perspective

Pharmacokinetic and pharmacodynamic differences can make drug development challenging for very young patients. One can think of pediatric medicines as one of the last uncharted frontiers in patient-centric drug development. Read about the many improvements in pediatric drug development that have occurred during the last 15 years and what is being done to continue moving forward.